Immuneering CorporationIMRXNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-6.37
↑ 54% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-13.98
Historical baseline
PeriodValueYoY Change
2025-6.37-431.7%
2024-1.20+71.7%
2023-4.24-48.4%
2022-2.85+79.3%
2021-13.77+15.0%
2020-16.20+69.6%
2019-53.25-